INTRODUCTION
============

In all eukaryotes transcription-associated recombination (TAR) governs fundamental processes such as cell viability, cell identity, and genome stability ([@B1]; [@B19]). In *Saccharomyces cerevisiae* TAR is particularly important at the ribosomal DNA (rDNA) array, which is composed of repeated sequences that can easily undergo genomic rearrangements caused by unequal recombination.

The rDNA is organized into ∼150--200 units repeated in tandem on chromosome XII ([@B43]). On each unit, RNA polymerases (Pols) I and III transcribe 35S and 5S ribosomal RNAs, respectively. The Pol I-- and Pol III--transcribed sequences are interrupted by nontranscribed spacers (NTSs), which contain *cis*-regulatory elements for the control of DNA replication (the autonomous replication sequence) and transcription (the 35S and 5S promoters, as well as a putative enhancer; [Figure 1](#F1){ref-type="fig"}; [@B40]).

![Schematic map of ribosomal genes in *S. cerevisiae*. Horizontal black arrows, RNA transcripts. Filled black boxes, 35S and 5S coding units. Gray boxes, E-PRO and C-PRO promoters. White box, putative transcriptional enhancer. ARS, origin of DNA replication. Ellipses, positioned nucleosomes ([@B59]). Thin horizontal white arrow, strand-specific oligonucleotide used in the RT-PCR reactions. Thick black lines, PCR amplicons produced in ChIP analyses.](2770fig1){#F1}

Because the ribosomal RNAs are essential to support protein synthesis, the number and sequence identity of their genes are actively maintained by the cells. Homologous recombination ensures this; however, mitotic recombination among the repeated units must be tightly regulated to avoid genome instability ([@B29]; [@B16]).

[@B30]) proposed a model of TAR at rDNA in which RNA Pol II transcription of NTS induces unequal recombination through the dissociation of cohesin complexes from aligned sister chromatids. This process can result in two different outcomes: intrachromatid recombination, which generates extrachromosomal ribosomal circles (ERCs); or interchromatid recombination between misaligned sister chromatids, which gives rise to rDNA copy number variation ([@B30]). Both these events have been shown to determine aging in yeast ([@B48]; [@B17]).

RNA Pol II transcription of rDNA starts from two promoters, called C-PRO and E-PRO, lying at the beginning and at the end of the 35S coding sequence, respectively ([Figure 1](#F1){ref-type="fig"}; [@B45]; [@B30]; [@B32]). Pol II transcription from the E-PRO and C-PRO promoters generates noncoding RNAs (ncRNAs; [@B32]; [@B24]; [@B57]). ncRNA expression has been shown to be associated with altered ribosomal recombination in different genetic backgrounds ([@B30]; [@B24]; [@B57]).

In a wild-type cell the synthesis of these ncRNAs appears to be transcriptionally repressed. Previous reports showed the existence of Pol II transcriptional repression at rDNA. In 1997 a form of transcriptional silencing was shown for reporter genes, transcribed by Pol II, artificially inserted in the ribosomal locus ([@B6]; [@B49]). A number of genes were shown to control this kind of ribosomal transcriptional silencing ([@B50]), most of which regulate chromatin structure and dynamics: the core histones and the histone chaperone *CAC1* ([@B6]; [@B50]), the histone deacetylases Rpd3p and Sir2p ([@B6]; [@B50]; [@B53]; [@B55]), the chromatin-remodeling complexes Isw1 and Isw2 ([@B37]; [@B38]), and the histone methyltransferase Set1p ([@B7]).

Of interest, mutations in the NAD^+^-dependent histone deacetylase Sir2p increase both ncRNA transcription and ribosomal recombination ([@B28]; [@B32]). The chromatin structure of *sir2Δ* strains shows hyperacetylation and hyperaccessibility to micrococcal nuclease digestion at rDNA ([@B15]; [@B11]). These observations suggest that ncRNA transcription and recombination of ribosomal genes may be under chromatin-mediated control. However, the relationship between chromatin modifications and transcription-associated recombination at rDNA has not been clearly characterized.

To gain further understanding on the role of chromatin in homologous recombination and ncRNA transcription in the ribosomal cluster, we investigated these molecular events in mutants of histone deacetylases and chromatin architectural factors.

RESULTS
=======

ERC production is controlled by several chromatin regulators
------------------------------------------------------------

The involvement of chromatin in the control of both ribosomal ncRNAs transcription and rDNA recombination is particularly evident in the *sir2Δ* mutant. This strain shows a loss of silencing phenotype with ncRNA accumulation ([@B6]; [@B32]). Moreover, its ribosomal repeats are highly unstable, with frequent intra­chromatid recombination events generating ERCs ([@B20]; [@B28]). The accumulation of ERCs in *sir2Δ* cells is one of the causes of their shortened lifespan ([@B28]). Considering that Sir2p is a histone deacetylase ([@B27]; [@B54]) and that the mutant\'s chromatin is hyperaccessible ([@B15]; [@B11]), we tried to clarify the role of histone acetylation and chromatin structure in recombination, in terms of ERCs formation, and in ncRNA transcription. To accomplish this task, we performed a biased screening, starting from the measure of ERCs on selected chromatin mutants ([Figure 2](#F2){ref-type="fig"}).

![Chromatin regulators control ERC formation. (A) Southern analysis of ERC species. DNA was isolated from the specified yeast strains or after 16 h treatment with 500 μM NAM, and probed with a radiolabeled rDNA sequence. ERCs are indicated by arrows. The differences in the migration of bands corresponding to ERCs are due to different durations of electrophoretic migration. (B) Quantification of ERC amount. Averages and SDs of at least three independent experiments are reported. Two-tailed *t* test was applied for statistical analysis. Asterisks indicate statistically relevant differences; α = 0.05. The p values are as follows: *sir2*, p = 0.0419; *NAM*, p = 0.0086; *rpd3*, p = 0.0454; *hst1*, p = 0.1388; *hst2*, p = 0.6499; *hst3*, p = 0.0083; *hst4*, p = 0.1529; *nhp6ab*, p = 0.0474.](2770fig2){#F2}

The *HST1-4* genes code for NAD^+^-dependent histone deacetylases, which share a significant sequence identity with the *SIR2* gene ([@B4]), giving rise to the *S. cerevisiae* sirtuin family. We measured ERCs on single mutants of *SIR2* and *HST1-4* genes and on a panel of other strains as follows. First, we analyzed *WT* cells treated with 500 μM nicotinamide (NAM), a sirtuin noncompetitive inhibitor that increases rDNA recombination and shortens replicative lifespan ([@B3]). Second, we extended the study to the mutant in a Zn^+^-dependent histone deacetylase, Rpd3p, unrelated to sirtuins. This enzyme antagonizes Sir2p in the establishment of silenced chromatin at telomeres, HM loci, and rDNA ([@B50]; [@B55]; [@B62]; [@B14]), and a mutation in the *RPD3* gene decreases the level of genomic recombination ([@B13]). Finally, we investigated the involvement of high-mobility-group Nhp6p proteins, which are chromatin architectural factors ([@B52]). The double mutation of *NHP6A* and *NHP6B* genes results in a decreased amount of histones, which determines chromatin hyperaccessibility ([@B9]) and ERC accumulation, with a consequent shortened lifespan ([@B18]).

To measure ERCs, we subjected whole genomic DNA purified from logarithmically growing cultures to electrophoresis and transferred it to a nitrocellulose filter by Southern blotting. The ERC species are detected as fast-migrating bands after hybridization with a radiolabeled probe (arrows in [Figure 2A](#F2){ref-type="fig"}). Quantification of ERCs, obtained by normalizing the ERC level to the loaded genomic amount of each strain, is reported in [Figure 2B](#F2){ref-type="fig"}. The graphs show the ERCs amount for each strain, or treatment, relative to the isogenic WT or untreated sample, indicated as 1. Data presented in this form allow a direct evaluation of fold changes in the different genetic backgrounds.

The *sir2Δ* strain shows increased ERCs levels, as previously described ([@B28]). In addition, NAM treatment of WT cells results in ERC accumulation, demonstrating that sirtuin catalytic activity is crucial to repressing recombination at rDNA. This finding was previously reported by measuring the rate loss of marker genes integrated at rDNA ([@B3]). Here we confirm the data specifically for intrachromatid recombination, which leads to ERC production.

Conversely, we observed almost complete absence of ERCs in cells lacking the histone deacetylase Rpd3p. As far as the *HST1-4* sirtuins are concerned, we observed a significant increase in ERC amount in the *hst3* mutant, whereas the extent of ERC formation was not affected by the other *hst* gene deletions. Finally, the *nhp6ab* double mutation enhances recombination at rDNA, as expected ([@B18]).

Taken together, these data indicate that rDNA recombination is suppressed by *HST3* and *NHP6AB* gene activity, besides that of the known *SIR2*. Moreover, global deacetylation activity on account of Rpd3p seems to be correlated with ERC production.

Altered ERC production corresponds to changes in ncRNA transcription
--------------------------------------------------------------------

Previous studies indicated that the synthesis of ncRNAs at rDNA mediated by RNA polymerase II is related to instability of the ribosomal array. The most accepted model suggests that recombination regulation among the repeated units of the ribosomal cluster is achieved through ncRNA transcription ([@B30]).

To show whether ERC accumulation is stimulated by ncRNA transcription in our mutants, we analyzed the ribosomal ncRNA produced from the bidirectional promoter E-PRO ([Figure 3A](#F3){ref-type="fig"}). In fact, E-PRO activity is directly involved in rDNA recombination, which is abolished when E-PRO is deleted or replaced with a unidirectional promoter ([@B30]). The NTS1-R ncRNA ([Figure 3A](#F3){ref-type="fig"}) level was measured by reverse transcription-PCR (RT-PCR), using a strand-specific primer. PCR coamplification with an oligo pair for *ACT1* was performed in order to normalize the data. [Figure 3B](#F3){ref-type="fig"} reports the ncRNA level for each mutant and condition, expressed as ratio relative to the isogenic WT or untreated sample, respectively.

![ERC formation is stimulated by ncRNA transcription. (A) Schematic map of the rDNA unit. Thin horizontal black arrows, ncRNAs produced from E-PRO and C-PRO promoters. Horizontal white arrow, oligo NTS1-R used in the strand-specific RT-PCR. (B) Quantification of the ncRNA expression level. The histograms indicate the averages and SDs from three independent experiments. Two-tailed *t*-test was applied for statistical analysis. Asterisks indicate statistically relevant differences; α = 0.05. The p values are as follows: *sir2*, p = 0.0006; *NAM*, p = 0.002; *rpd3*, p = 0.0013; *hst1*, p = 0.0703; *hst2*, p = 0.1451; *hst3*, p = 0.0047; *hst4*, p = 0.125; *nhp6ab*, p = 0.0454.](2770fig3){#F3}

*SIR2* deletion leads to a twofold increase in the ncRNA expression, as previously reported ([@B32]). In addition, the NAM treatment causes an up-regulation of ncRNA, even though the effect is less marked than in the *sir2Δ* mutant. The *rpd3* mutant strain shows a significant reduction in ncRNA levels, consistent with the demonstrated role of this histone deacetylase in counteracting rDNA transcriptional silencing ([@B50]; [@B55]). The *hst3* mutant accumulates ncRNA. On the contrary *hst1Δ*, *hst2Δ*, and *hst4Δ* strains show only slight differences in the production of this ncRNA transcript. Moreover, Pol II transcription of rDNA in the *nhp6ab* double mutant is threefold higher than its isogenic WT, providing the first evidence of the involvement of the high-mobility-group proteins in the regulation of ncRNA production.

Of interest, we observed strong correspondence between ERC production ([Figure 2](#F2){ref-type="fig"}) and ncRNA expression profiles ([Figure 3](#F3){ref-type="fig"}) in the analyzed chromatin mutants. In fact, mutants that produce more ERCs (*sir2*, *hst3*, and *nhp6ab*) also show elevated levels of ncRNA transcription. On the other hand, in the *rpd3* mutant, rDNA recombination is partially suppressed and ncRNA expression significantly decreased.

In the mutants studied, the data are consistent with the model according to which ERC production is stimulated by ncRNA transcription ([@B30]).

Histone H4 acetylation correlates with ERC and ncRNA production
---------------------------------------------------------------

The foregoing data suggest a strong influence of the chromatin regulators (histone deacetylases and chromatin architectural factors) on the control of rDNA recombination mediated by ncRNA transcription. This last process was shown to be associated with changes in the histone acetylation pattern at rDNA ([@B10]).

To uncover the relationship between histone acetylation and transcription-induced recombination at rDNA, we analyzed the global acetylation level of histone H4 in all our strains. Indeed, the acetylation state of lysines within the N-terminal of this histone is crucial for the silencing control at telomeres, HM loci, and rDNA ([@B21]; [@B5]; [@B27]; [@B23]; [@B62]).

We assessed H4 histone acetylation through a chromatin immunoprecipitation (ChIP) approach ([@B44]). Chromatin extracts were immunoprecipitated with antibodies against the C-terminal region of histone H4 or the N-terminal acetylated form (at lysines 5, 8, 12, and 16). The immunoprecipitated DNA was analyzed by PCR using specific primers for six different rDNA regions: the 35S coding sequence (COD), the putative Pol I transcriptional enhancer (ENH), the E-PRO and C-PRO promoters, a region with highly positioned nucleosomes (NUC), and the ARS sequence (map details in [Figures 1](#F1){ref-type="fig"} and [4A](#F4){ref-type="fig"}). Considering that *SIR2* mutations affect the total occupancy of histone H3 at rDNA ([@B32]) and that the *nhp6ab* mutant shows a genome-wide reduction of nucleosome particles ([@B9]), we decided to normalize histone H4 acetylation to the whole H4 amount in all the strains. In addition, in the graphs, data are reported relative to the wild-type level of acetylation (blue line, [Figure 4B](#F4){ref-type="fig"}).

![The H4 acetylation profile is altered at the rDNA of histone deacetylases and mutants of high-mobility-group proteins. (A) Graphical representation of an rDNA unit. Horizontal thick black lines indicate the positions of PCR amplicons generated by the ChIP experiments (not to scale). (B) ChIP analysis of the histone H4 acetylation profile at rDNA. Chromatin from the specified strains was immunoprecipitated with antibodies against the C-terminal tail of histone H4 (H4 C-TERM) or against the histone H4 acetylated at lysines 5, 8, 12, and 16 (ACH4). The graphs show the acetylation enrichment, in the indicated rDNA regions, of the mutants relative to isogenic WT strain, reported as 1 (blue line). The lines show the average ratios and SD of technical replicates in a representative experiment out of two performed.](2770fig4){#F4}

When the *sir2Δ* strain was compared with the WT, a strong increase in histone H4 acetylation throughout the nontranscribed spacer is observed, confirming previous observations ([@B7]; [@B11]). Similar results are obtained after inhibition of sirtuin catalytic activity by NAM. However, NAM increases histone acetylation to a lesser extent than does *SIR2* deletion.

Unexpectedly, mutation of the histone deacetylase Rpd3p results in a significant decrease in the H4 acetylation level at rDNA. Similar results were reported for *rpd3* mutants at telomeres; specifically, this is true for H4K12 in yeast ([@B14]) and for several H4 lysine residues in *Drosophila* ([@B8]). Our observation represents the first evidence of hypoacetylation at rDNA of *rpd3* mutants.

Then we analyzed the H4 acetylation level in all *hst1-4* mutants. We found that *hst3* and *hst4* strains show, on average, a 1.5-fold increase in H4 acetylation at all the analyzed regions ([Figure 4](#F4){ref-type="fig"}), even though the deacetylation activity of these proteins has been reported only for histone H3 lysine 56 ([@B60]; [@B61]). For *hst1* and *hst2* mutants we could not detect any significant variation relative to the isogenic WT strain (unpublished data).

An increase of histone H4 acetylation in the NTS is also evident for mutant strains lacking the *NHP6A* and *NHP6B* genes, suggesting a misregulation in the balance of acetylation/deacetylation in mutants of the high-mobility-group proteins.

To verify whether the alteration in histone acetylation involves other silenced regions, we extended the ChIP analysis to the telomere of the right arm of chromosome VI (Supplemental Figure S1B). We found changes in the acetylation patterns for *sir2Δ*, *rpd3Δ*, and NAM-treated cells, similar to what happens at rDNA. Conversely, in *hst3* and *nhp6ab* mutants, no alteration in the level of histone H4 acetylation is observed at telomeres, indicating that their effect on H4 acetylation is restricted to the ribosomal locus (Supplemental Figure S1B).

Strikingly, the data reported in [Figures 2--4](#F2 F3 F4){ref-type="fig"} show a clear association between ERC production, ncRNA transcription, and histone H4 acetylation among the strains analyzed. In fact, mutants with alterations in ERC and ncRNA levels also show a corresponding change in the histone H4 acetylation. However, the analyses performed so far do not allow us to discriminate which lysine residues account for the observed differences, because of the multiple recognition specificity (lysines 5, 8, 12, and 16) of the antibody used in the ChIP assay.

H4K16 acetylation overlaps with H4 global acetylation in chromatin mutants
--------------------------------------------------------------------------

We then decided to measure the acetylation level of the H4K16 residue in all mutants for the following reasons: 1) H4K16 acetylation has been found to be associated with Pol II transcription in euchromatic regions in all eukaryotes ([@B36]); 2) its deacetylation is crucial for transcriptional silencing at all three silent loci in yeast ([@B21]; [@B5]; [@B23]); and 3) H4K16 is the main deacetylation target of Sir2p, the silencing mediator ([@B27]). Considering the changes in ncRNA transcription in the mutants studied, it is conceivable that acetylation of this residue plays a role in the alterations of the silencing process at rDNA.

When ChIP extracts were immunoprecipitated with antibodies against the acetylated form of H4K16 (H4K16-ac), the overall result, obtained after normalization to the total amount of histone H4, was similar to that shown for the globally acetylated form of H4 ([Figure 5](#F5){ref-type="fig"}; also see ACH4 reported in [Figure 4](#F4){ref-type="fig"}).

![The alterations in H4 Lys-16 acetylation correlate with the observed changes in global H4 acetylation. (A) Schematic map of the rDNA repeat. The fragments amplified in the ChIP analyses are shown. (B) ChIP analysis of the histone H4 Lys-16 acetylation at rDNA. As in [Figure 4B](#F4){ref-type="fig"}, except that the antibodies used were against the C-terminal tail of histone H4 (H4 C-TERM) or against H4 acetylated at Lys-16 (H4K16-ac).](2770fig5){#F5}

By comparing the acetylation profiles of the *sir2* mutant, obtained with αH4K16-ac and αACH4 antibodies, we observed that H4K16 acetylation increases to a lesser extent. Possibly this is due to the fact that H4K16 is not the only residue whose acetylation increases in the *sir2* mutant ([@B5]). The NAM treatment appeared to inhibit with different efficiency H4K16-ac and ACH4. In fact, NAM-treated cells show the same H4K16 acetylation extent as the *sir2∆* strain, whereas this is not evident for the global H4 acetylation.

According to the previous results ([Figure 4](#F4){ref-type="fig"}), the *rpd3* mutant shows a sharp decrease in the H4K16 acetylation in all the rDNA regions studied. Acetylation of the *hst3* and *hst4* mutants seems to be slightly affected, whereas the effect of *nhp6* mutation is, again, higher. Moreover, Hst3p, Hst4p, and Nhp6p seem to influence H4K16 acetylation specifically at rDNA, as confirmed by the fact that the acetylation extent of a subtelomeric region of the telomere VI is not altered in the mutant strains (Supplemental Figure S1C).

Because Hst3p and Hst4p deacetylases are known to act on H3K56 and Rpd3p is specific for H4K12 (among other lysines), we evaluated the acetylation extent of these residues (Supplemental Figure S2). We found a slight decrease in H4K12-ac and a small increase in H3K56-ac at the rDNA of *rpd3* and *hst3* mutants, respectively. Conversely, no significant changes were observed when the analysis was extended to the telomeres of these strains (Supplemental Figure S2).

Taken together, the data highlight a clear selective H4K16 acetylation accumulation ([Figure 5](#F5){ref-type="fig"}) at the ribosomal locus in those mutants where both ncRNA and ERC amounts are increased (*sir2*, *nhp6ab*, and, partially, *hst3*). Correspondingly, in the *rpd3* mutant, hypoacetylation of H4K16 seems to be related to a decrease in both ERC and ncRNA production ([Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, and [5](#F5){ref-type="fig"}).

H4K16 acetylation controls ERC accumulation and ncRNA transcription
-------------------------------------------------------------------

To unambiguously attribute a role to H4K16 acetylation as a key regulator of recombination and Pol II transcription at rDNA, we used yeast strains bearing substitutions of H4K16 to arginine (*H4K16R*) or glutamine (*H4K16Q*). These two modifications mimic the unacetylated or acetylated state of the residue, respectively. *H4K16R* and *H4K16Q* mutations were previously shown to alter silencing in yeast ([@B21]; [@B35]; [@B23]).

In [Figure 6](#F6){ref-type="fig"} we report results on DNA recombination, measured as ERC accumulation ([Figure 6A](#F6){ref-type="fig"}), and Pol II transcription, measured as ncRNA production ([Figure 6B](#F6){ref-type="fig"}). *H4K16Q*, *H4K16R*, and their isogenic WT strains were grown to the exponential phase and ERC species analyzed as described in [Figure 2](#F2){ref-type="fig"}. The *H4K16Q* strain shows a twofold increase in ERC content relative to the isogenic WT. In contrast, the *H4K16R* mutation maintains the amount of ERC at the level of WT ([Figure 6A](#F6){ref-type="fig"}).

![Deacetylation of H4K16 is required for the suppression of ERC formation and ncRNA transcription. (A) Substitution of histone H4 Lys-16 with glutamine increases ERC production. Quantification of ERC amount produced by yeast strains bearing substitutions of H4K16 to glutamine, *H4K16Q* (left), or to arginine, *H4K16R* (right). ERC species were quantified and normalized as described in [Figure 2](#F2){ref-type="fig"} (n \> 3; ±SD). Two-tailed *t* test was applied for statistical analysis. Asterisk indicates the statistically relevant difference, α = 0.05, between WT (PKY501) and *H4K16Q* (p = 0.0204) strains. (B) The *H4K16Q* mutant up-regulates ncRNA transcription at rDNA. Measure of the E-PRO--derived ncRNA expression level of *H4K16Q* (left), *H4K16R* (right), and the corresponding isogenic WT as in [Figure 3](#F3){ref-type="fig"} (n = 3; ±SD). Asterisk indicates the statistically relevant difference, α = 0.05, between WT (PKY501) and *H4K16Q* (p = 0.0264) strains.](2770fig6){#F6}

We then measured the ncRNA expression level, derived from the E-PRO promoter, as in [Figure 3](#F3){ref-type="fig"}. [Figure 6B](#F6){ref-type="fig"} shows how, even in this case, *H4K16Q* mutation causes loss of silencing at rDNA, with an increased steady-state level of ncRNA, whereas the *H4K16R* strain seems to produce ncRNA at a similar rate as the WT.

Overall these data indicate that the replacement of the positively charged lysine residue 16 with a neutral one is sufficient to induce a coordinated deregulation of both ncRNA transcription and recombination, thereby suggesting a pivotal role of H4K16 acetylation for the control of TAR at rDNA.

The *nhp6ab* mutation affects SIR2 expression
---------------------------------------------

The results reported here show that H4 Lys-16 acetylation is sufficient to control TAR at rDNA, because in *H4K16Q* mutants both processes are affected. In addition, in *sir2*, *rpd3*, *hst3*, and *nhp6ab* mutant strains a clear relationship between the acetylation state of H4K16 and recombination regulation by ncRNA is observed.

A direct interpretation of the mechanism underlying these phenotypes is possible only for the *sir2Δ* strain, since only Sir2p deacetylates H4K16 both in vitro and in vivo. A possible explanation for the observed variations in H4K16 acetylation in the other mutants could be defective recruitment of Sir2p at the ribosomal array.

We tested this hypothesis by measuring Sir2p binding at rDNA by ChIP analysis. Chromatin extracts of *rpd3*, *hst3*, and *nhp6ab* mutants were immunoprecipitated with αSir2 antibodies, and DNA was amplified in two regions, ENH and C-PRO, previously shown to be specifically bound by Sir2p ([@B25]). We found that the Sir2p enrichment at rDNA of the *nhp6ab* mutant drops relative to the isogenic WT ([Figure 7A](#F7){ref-type="fig"}). Conversely, *rpd3* and *hst3* mutants did not show significant changes in the level of Sir2p recruitment (Supplemental Figure S3). The reduction observed in the *nhp6ab* strain involves both regions to a very similar extent.

![The *nhp6ab* mutant has reduced *SIR2* expression. (A) The *nhp6ab* double mutant leads to the loss of Sir2p from the rDNA locus. WT and *nhp6ab* strains were subjected to ChIP analysis with antibodies against Sir2p. The recovered DNA was amplified in two regions known to bind Sir2p---the enhancer (ENH) and the C-PRO promoter. (B) Sir2 mRNA expression is reduced in *nhp6ab* cells. The graph reports the Sir2 mRNA levels of *nhp6ab* and WT strains measured by RT-PCR (n = 3; ±SD). (C) The *nhp6ab* mutant cells have a decreased Sir2 protein level. Protein extracts from three independent cell cultures of WT (left) or *nhp6ab* (right) cells were analyzed by Western blot with anti-Sir2 and anti--α-tubulin antibodies.](2770fig7){#F7}

We hypothesized that the proportional decline of Sir2p binding at C-PRO and ENH could reflect a general reduction in Sir2p availability in *nhp6ab* mutants. To verify this hypothesis, we measured SIR2 mRNA expression and protein level by RT-PCR and Western blot ([Figure 7](#F7){ref-type="fig"}). Compared to the WT, the mutant shows a twofold reduction of SIR2 mRNA levels ([Figure 7B](#F7){ref-type="fig"}), and the Sir2 protein amount is even more reduced ([Figure 7C](#F7){ref-type="fig"}).

To verify whether the effects of *nhp6ab* mutation are limited to the ribosomal locus, we also measured the Sir2p recruitment at telomere VI R. We found only a slight decrease in Sir2p binding at the telomere (Supplemental Figure S4A). Indeed, telomeric silencing of *nhp6ab* is unaffected, indicating that the observed decrease is not influential (Supplemental Figure S4B).

*SIR2* overexpression restores most of the WT phenotypes in the *nhp6ab* mutant
-------------------------------------------------------------------------------

The increase in ncRNA transcription, ERC accumulation, and H4 hyperacetylation in the *nhp6ab* mutant may all be explained by the observed decrease in the *SIR2* gene product ([Figure 7](#F7){ref-type="fig"}). If this were the case, the ectopic expression of the *SIR2* gene should restore rDNA silencing, the control of recombination, and the WT level of acetylation in the *nhp6ab* strain.

Thus we transformed *nhp6ab* and WT cells with the pAR44 plasmid, in which *SIR2* is under the control of the GAL10 promoter ([@B22]). These transformants were compared with cells transformed with an empty vector for ncRNA production ([Figure 8A](#F8){ref-type="fig"}), H4 histone acetylation ([Figure 8, B and C](#F8){ref-type="fig"}), and ERC formation ([Figure 8D](#F8){ref-type="fig"}). All the strains were grown in galactose to induce *SIR2* expression.

![*SIR2* overexpression restores the WT level of ncRNA transcription and H4 acetylation in the *nhp6ab* mutant. (A) *SIR2* overexpression in the *nhp6ab* mutant restores the levels of ncRNA transcription. WT and *nhp6ab* cells were transformed with the pAR44 plasmid (+) or with the empty vector (--). Quantification of ncRNA expression was performed as described in [Figure 3](#F3){ref-type="fig"} (n ≥ 4; ±SD). Two-tailed *t* test was applied for statistical analysis. Asterisks indicate the statistically relevant differences between *nhp6ab* cells with or without *SIR2* overexpression (α = 0.01; p = 0.0015) or between WT cells with or without *SIR2* overexpression (α = 0.01; p = 0.009). (B) *SIR2* overexpression rescues the altered histone H4 acetylation of the *nhp6ab* mutant. Cells overexpressing (+) or not (--) *SIR2,* were grown in galactose and processed for ChIP analysis with antibodies against the C-terminal tail of histone H4 or against the acetylated histone H4 (ACH4). Quantification details and positions of PCR fragments are as in [Figure 4](#F4){ref-type="fig"}. (C) The increased H4K16 acetylation of *nhp6ab* drops to the WT level after *SIR2* overexpression. As in B, except that the antibodies were anti--acetyl histone H4-Lys-16 (H4K16-ac) and anti--H4 C-terminal tail (H4 C-TERM). (D) *SIR2* overexpression does not reduce the ERC levels in the *nhp6ab* strain. DNA from cells containing the PAR44 plasmid (+) or the empty vector (--) was extracted and processed for ERC analysis as described in [Figure 2](#F2){ref-type="fig"} (n = 3; ±SD).](2770fig8){#F8}

In this case, the ncRNA expression value of WT cells transformed with the empty plasmid was used as normalizer and is reported as 1 in the graph in [Figure 8A](#F8){ref-type="fig"}. We observed a significant reduction of ncRNA expression for the *nhp6ab* mutant overexpressing *SIR2* when compared with the same strain without the ectopic expression of *SIR2*. WT cells transformed, as control, with pAR44 also show a significant reduction of ncRNA relative to the corresponding WT strain without *SIR2* overexpression. A parallel analysis was performed on cells grown in the repressive glucose-containing medium. However, because of the leakiness of the GAL10 promoter ([@B31]), a conspicuous SIR2 expression was detected, and the restoration of ncRNA silencing in *nhp6ab* mutant was observed (unpublished data).

The phenotype rescue analysis was extended to the global H4 acetylation levels (ACH4) in the different rDNA regions of the same strains studied earlier ([Figure 8B](#F8){ref-type="fig"}). The measure of H4 acetylation was performed by ChIP, as reported in [Figure 4](#F4){ref-type="fig"}. When WT cells containing pAR44 are compared with WT cells transformed with the empty plasmid, a similar acetylation profile is observed in most of the regions analyzed. Conversely, a sharp decrease of H4 acetylation is evident in the *nhp6ab* mutant that overexpresses *SIR2* relative to *nhp6ab* cells without *SIR2* ectopic expression. Indeed, *SIR2* overexpression makes the H4 acetylation levels almost identical in WT and *nhp6ab* cells.

We further analyzed the specific acetylation of histone H4 at the Lys-16 residue (H4K16-ac). The acetylation profiles ([Figure 8C](#F8){ref-type="fig"}) are comparable to those observed with αACH4 antibodies. This further demonstrates that the H4K16 acetylation overlaps with H4 global acetylation at the rDNA locus.

The ncRNA expression and the H4 acetylation levels obtained with cultures using glucose as carbon source ([Figures 3--5](#F3 F4 F5){ref-type="fig"}) show similar profiles, but different absolute values, compared with those observed when cells are grown in galactose ([Figure 8](#F8){ref-type="fig"}). Given that Sir2p is a NAD^+^-dependent enzyme, and given its pivotal role in these processes, changes due to the metabolic alterations are conceivable.

The same strains were also analyzed for ERC production ([Figure 8D](#F8){ref-type="fig"}). However, for this phenotype, *SIR2* overexpression did not restore the WT level of recombination.

DISCUSSION
==========

Chromatin factors control TAR at rDNA
-------------------------------------

The rDNA is one of the few repeated regions in the genome of the yeast *S. cerevisiae*. Because of its repetitive nature, rDNA may undergo unequal recombination among the units. This latter event is normally suppressed by the yeast cell to avoid ERC production and, in general, genomic instability at the ribosomal array. Despite its potentially detrimental role, a basal level of recombination is required ([@B26]). rDNA mitotic recombination is ensured, at least in part, by the Pol II transcription of ncRNAs, through a transcription-associated recombination mechanism ([@B30]).

Pol II transcriptional silencing at rDNA is regulated by multiple pathways and is possibly controlled by the nucleation of a specialized chromatin structure, since it requires histone hypoacetylation ([@B6]; [@B50]; [@B32]), histone methylation ([@B7]; [@B32]), and chromatin-remodeling enzymes ([@B37]; [@B38]). The chromatin structure was also found to affect rDNA recombination efficiency ([@B28]; [@B18]).

Despite the fact that several studies indicated chromatin involvement in both ncRNA transcription and ERC formation at rDNA, direct evidence connecting the two processes through chromatin structure is lacking.

We developed a small, biased screening to find chromatin factors involved in both ERC formation and ncRNA transcription. In brief, we found that the histone deacetylase Hst3p and the chromatin architectural components Nhp6p are able to inhibit both processes in vivo, whereas the histone deacetylase Rpd3p acts in the opposite way ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

Hst3p and Hst4p regulate transcriptional silencing. Indeed, they are required for efficient H3K56 deacetylation at telomeres and HM loci, where they suppress the expression of both integrated reporter genes and endogenous transcripts ([@B33]; [@B60]; [@B61]). However, only the double mutant *hst3/hst4* leads to these phenotypes, probably because Hst3p and Hst4p perform H3K56 deacetylation during different phases of the cell cycle ([@B33]). Consistently, we found no variation in the content of acetylated H3K56 at telomere VI and observed only a slight H3K56 hyperacetylation at the rDNA of the single mutant *hst3* (Supplemental Figure S2). The experiments reported here show how the *hst3* mutant is characterized by hyperrecombination of the ribosomal cluster with ncRNA accumulation in a cell cycle--independent manner, even when individually mutated. Previously reported data ([@B56]) indicate that, among the *hst* mutants, *hst3* is characterized by a strong lifespan reduction. The ERC-proficient phenotype that we found for the *hst3* mutant is in complete agreement with the role of rDNA recombination in replicative aging.

In absence of Rpd3p, ribosomal silencing is enhanced for integrated reporter genes ([@B50]; [@B55]). Moreover, this deacetylase seems to be important for global genomic recombination regulation. Here we show that these two phenotypes are intimately linked at rDNA and controlled by Rpd3p in vivo. Indeed, the *RPD3* deletion suppresses ncRNA production and causes a strong reduction of ERCs. Of interest, despite its deacetylase activity, the loss of Rpd3p function gives rise to phenotypes opposite to those observed in *sir2* mutants at telomeres, HM, and ribosomal loci.

*S. cerevisiae* Nhp6Ap and Nhp6Bp are chromatin architectural factors that bind to the minor groove of double-stranded DNA in a non--sequence-specific manner ([@B2]) and thereby influence chromatin structures ([@B34]; [@B9]). Previous work showed that the *nhp6ab* double mutant leads to increased genome instability, ERC accumulation, and strong reduction of replicative lifespan ([@B18]). The mechanism by which Nhp6p contributes to reduce genome instability was associated with the control of histone content ([@B9]).

With regard to the ribosomal locus, the *nhp6ab* mutant loses Pol II silencing, with a strong production of ncRNA. We suggest that transcription-associated recombination may be one of the mechanisms by which *NHP6AB* genes control ERC formation at rDNA. However, ERC levels are not reduced by *SIR2* overexpression in *nhp6ab* mutants ([Figure 8D](#F8){ref-type="fig"}). This suggests that the chromatin alterations in this strain are sufficient to trigger recombination at rDNA despite a reduction in the level of ncRNA.

Altered histone H4 acetylation is associated with variations of both Pol II transcription and recombination
-----------------------------------------------------------------------------------------------------------

Despite the different ways by which the studied genes act on chromatin, we observed that some of the mutants show alterations in histone H4 acetylation pattern at rDNA. These modifications are associated with transcriptional and recombinational defects ([Figures 2--4](#F2 F3 F4){ref-type="fig"}). In particular, the H4K16 acetylation level strongly correlates with ncRNA transcription and ERC formation ([Figure 5](#F5){ref-type="fig"}). In fact, mutants that produce more ERCs and ncRNA (*sir2*, *hst3*, and *nhp6ab*) also show increased levels of acetylation in many regions of rDNA.

We provide the first evidence that the two proteins Hst3p and Hst4p modulate H4K16 acetylation ([Figure 5](#F5){ref-type="fig"}). In fact, they were previously demonstrated to act on H3K56 ([@B33]; [@B60]; [@B61]). However, our experiments do not discriminate the direct effect on H4K16 from that mediated by histone modification cross-talk. In any case the effect of Hst3p-mediated H4K16 deacetylation seems to be specific to the ribosomal cluster. In fact, the *hst3* mutation has no effect on H4K16 acetylation at the telomere, either when individually mutated (Supplemental Figure S1) or in combination with the *hst4* mutation ([@B61]).

The altered histone acetylation observed in the *nhp6ab* mutant can be explained only by an indirect mechanism. In fact, no histone modification activity has been attributed to Nhp6p proteins. We interpreted this phenotype to be associated with the decreased Sir2p binding at rDNA due to a clear reduction of Sir2 expression ([Figure 7](#F7){ref-type="fig"}). We demonstrated this hypothesis by overexpressing *SIR2* in the *nhp6ab* mutant, thereby rescuing the wild-type levels of H4 acetylation and ncRNA transcription ([Figure 8](#F8){ref-type="fig"}). Sir2p redistribution in the *nhp6ab* mutant does not involve all the silent loci to the same extent. In fact, although at rDNA a sharp decrease of Sir2p binding is evident, at the telomeres only a slight reduction is observed. This difference in Sir2p binding is functionally verified by the measure of silencing and histone acetylation, which are affected at rDNA but not at telomeres.

In contrast, the *rpd3* mutation, which suppresses recombination and Pol II transcription, shows hypoacetylated chromatin all along the ribosomal repeat. This observation is counterintuitive, since the loss of a deacetylase should cause an increase in acetylation. Actually, Rpd3p was found to show a similar behavior also at the telomere. At this locus Rpd3p is necessary for heterochromatin boundary formation, inhibiting the SIR complex spreading along subtelomeric genes ([@B62]; [@B14]). Moreover*, rpd3* mutants show H4 hypoacetylation, particularly at Lys-16, also in the *Drosophila* telomeres ([@B8]). It was hypothesized that Rpd3p interacts with chromatin at boundary regions, where its activity on H4K12 and H4K5 would create a chromatin environment able to block Sir2p-dependent H4K16 deacetylation ([@B62]; [@B14]). It is conceivable that a similar mechanism occurs at the ribosomal locus, in which we observe strong H4K16 deacetylation in the absence of Rpd3p.

H4K16 acetylation regulates ncRNA transcription and ERC formation at rDNA
-------------------------------------------------------------------------

The observations reported here indicate that H4 acetylation, particularly at Lys-16, is related to the events of recombination and Pol II transcription, thereby suggesting the existence of epigenetic control in the coordination of these two basic DNA transactions within the ribosomal genes of *S. cerevisiae*. In this study we demonstrated the existence of such epigenetic control.

In fact, the substitution of Lys-16 with differently charged residues results in distinct outcomes. The *H4K16Q* substitution, mimicking the acetylated state of lysine, leads to a strong misregulation of ERC formation rate and Pol II transcription. Conversely, substitution with the nonacetylatable arginine, *H4K16R*, does not affect ncRNA transcription or recombination at rDNA ([Figure 6](#F6){ref-type="fig"}). It is unlikely that the observed variations are due to a different amount of Sir2p, since [@B12]) demonstrated that *H4K16Q* and *H4K16R* mutants show a similar amount of Sir2p bound to the ribosomal cluster. This raises the possibility that the chromatin environment, and specifically histone acetylation, more than the recruitment of silencing factors is required to regulate recombination and Pol II transcription at rDNA. The dominant role of histone acetylation at H4K16 in the establishment of yeast silent chromatin was recently highlighted ([@B42]).

The coordinated regulation of transcription and recombination that we found in this study is not observed in all the conditions affecting one of the two processes. For example, mutants in the histone methyltransferase Set1 show increased ncRNA transcription ([@B32]) without altering the rDNA recombination rate ([@B7]). On the other hand, yeast cells grown under calorie restriction conditions suppress recombination without changes in ncRNA synthesis ([@B51]). We identified new factors that coordinate the transcription and recombination controls at the ribosomal array. The fact that they all affect histone acetylation suggests that this posttranscriptional modification is the key to the coordination.

Considering that rDNA repetitions require sequence homogeneity maintenance, the use of recombination could have been selected by evolution as a strategy to maintain this homeostasis. However, it is necessary to finely tune its control to prevent genome instability. The use of a rapid and reversible posttranscriptional modification such as the histone acetylation of a single, locus-specific residue makes the control of recombinational events easier than acting directly on ubiquitous recombinational enzymes.

According to several observations, the transcriptional activity of RNA polymerase II within the nucleolus of *S. cerevisiae* enhances recombination levels among the ribosomal repeats ([@B41]; [@B30]; [@B24]; [@B57]). Transcription-associated recombination events are widespread in the genome and play important roles also in complex systems, such as the immunoglobulin class switch recombination in mammals ([@B39]). The coupling between transcription and recombination can be due to the chromatin-remodeling activity that drives the transcriptional event. Indeed, H4K16 acetylation is a recognized marker of transcriptionally active chromatin ([@B36]). Furthermore, this modification inhibits the formation of the 30-nm fiber ([@B47]), likely leading to a structural environment that favors strand exchange during recombination. Because the increase in histone acetylation improves both transcription and recombination, it represents a possible prerequisite for their coordination.

MATERIALS AND METHODS
=====================

Yeast strains, plasmids, and oligo sequences
--------------------------------------------

Yeast strains and plasmid used in this study are listed in Supplemental Table S1, and oligo sequences are listed in Supplemental Table S2.

Culture media and conditions
----------------------------

Yeast was grown and manipulated according to standard protocols ([@B46]). Nicotinamide (Sigma-Aldrich, St. Louis, MO) treatment was performed at the final concentration of 500 μM for 16 h.

ERC analysis
------------

Yeast cells grown to exponential phase (OD~600~ 0.5/ml) were lysed with lysis buffer (1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA) and glass beads (Sigma-Aldrich) by vigorous shaking. The DNA was then purified by three phenol--chloroform--isoamylic alcohol (24:24:1 \[vol/vol/vol\]) extractions and ethanol precipitation. Proteinase K (0.2 μg/μl) and RNase A (0.15 μg/μl) treatments were also performed. A 5-μg amount of the recovered DNA was run in 0.8% agarose gel electrophoresis (1.75 V/cm) and transferred onto a nylon membrane (GE Healthcare, Piscataway, NJ). Hybridization was performed with an rDNA-specific probe annealing from −100 to −2400 base pairs upstream of the RNA polymerase I transcription start site. Image acquisition was performed using the Typhoon 9410 Variable Mode Imager (GE Healthcare). The band intensities corresponding to ERCs were measured with ImageJ 1.42q (National Institutes of Health, Bethesda, MD) and normalized to the bulk genomic DNA (loading control). ERC values were then divided by the calculated WT level (shown as 1 in the graphs). Means and error bars refer to at least three independent ratios: (mutant or treatment)/(wild type). Student\'s *t* test was applied for statistical analysis; α = 0.05.

RT-PCR
------

RNA from logarithmically growing cultures was isolated as previously described ([@B58]). A 1.5-μg amount of DNase I--treated RNA was subjected to cDNA synthesis, starting from 0.1 μM strand-specific primers NTS1-Rf and ACT1-F (for ncRNA measurement) or 2.5 μM oligo(dT) (for evaluation of the *SIR2*, *YFR057W*, and *IRC7* mRNA expression levels) through incubation with 30 U of SuperScript III Reverse Transcriptase (Invitrogen, Grand Island, NY) for 30 min at 55°C.

A 1-μl amount of the resulting cDNAs was amplified by PCR coamplification using the NTS1-Rr and ACT1-R reverse primers for ncRNA analysis and the following primers pairs for *SIR2*, *YFR057W*, and *IRC7* expression analysis: ACT1-F/ACT1-R; SIR2-F/SIR2-R; YFR057W-F/YFR057W-R; and IRC7-F/IRC7-R.

PCR was performed under the following conditions: 95°C for 30 s, 55°C for 30 s, and 68°C for 1 min, with 17 cycles for *ACT1* and 24 cycles for ncRNA, *SIR2*, *YFR057W*, and *IRC7*. Taq polymerase was from Eppendorf (Hamburg, Germany). \[α-^32^P\]dATP (Amersham, GE Healthcare) was added to the reaction mixture (0.04 μCi/μl). Template titration for each sample was performed to evaluate the linear range of amplification. The amplified fragments were separated on a 6% acrylamide gel. Quantification was performed using ImageJ 1.42q. ncRNA, *SIR2*, *YFR057W*, or *IRC7* band intensity was normalized to *ACT1*. For ncRNA data, average (with standard deviations) refers to at least three independent ratios: (mutant or treatment)/(wild type). Student\'s *t* test was applied for statistical analysis; α = 0.05.

The average and the SD of three technical replicates in a representative experiment out of two performed are reported for *SIR2*, *YFR057W*, and *IRC7*.

Chromatin immunoprecipitation
-----------------------------

A 300-ml amount of culture was grown to exponential phase, cross-linked with 1% formaldehyde at room temperature for 15 min, and then incubated with 330 mM glycine for 10 min. Cells were then processed for ChIP as described ([@B25])

A 350-μg amount of chromatin extract was incubated with 2.5 μg of antibodies against Sir2p (Santa Cruz Biotechnology, Santa Cruz, CA) or 2.5 μl of antibodies against histone H3 or H4 C-terminal tail, anti--acetyl H4, anti--acetyl H4 Lys-16, anti--acetyl H4 Lys-12, or anti--acetyl H3 Lys-56 (Millipore, Billerica, MA). Chromatin--antibody complexes were isolated with protein A--Sepharose beads (Amersham, GE Healthcare) for 1.5 h at 4°C. The recovered DNA was resuspended in 200 μl for genomic (input) sample and in 50 μl for immunoprecipitated (IP) and beads only (BO) samples. Different DNA amounts were used as template for PCR in order to obtain comparable autoradiographic signals (1 μl of a 1:20 dilution for input, and 1 μl for IP and BO. PCR was performed under the following conditions: 95°C for 30 s, 55°C for 30 s, and 68°C for 1 min, with 25 cycles for ACT1 and TEL VI and 18 cycles for rDNA sequences. \[α-^32^P\]dATP was added to the reaction mixture (0.04 μCi/μl). For each immunoprecipitation three PCR reactions were performed.

The amplified fragments were separated on a 6% acrylamide gels. Quantification was performed using ImageJ 1.42q. Each set of experiments was repeated at least twice. Quantifications were performed as described in [@B25]). Briefly, in [Figure 7](#F7){ref-type="fig"} and in Supplemental Figure S3 the Sir2 fold enrichment values were calculated as follows: \[rDNA(IP)/ACT1(IP)\]/\[rDNA(input)/ACT1(input)\].

In [Figures 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, and [8](#F8){ref-type="fig"} and Supplemental Figures S1 and S2 the acetylation profiles were further corrected for the total amount of the histone H4 or H3. In this case the relative fold enrichment is defined as the ratio (acetylated histone)/(total histone) for values from the following calculation: \[rDNA(IP)/ACT1(IP)\]/\[rDNA(input)/ACT1(input)\]. The isogenic WT strain value was then normalized to 1, obtaining the acetylation enrichment shown for the different mutants or conditions. The graphs show the mean and SD calculated from three technical replicates in a representative experiment out of two performed.

Western blot
------------

Yeast cells were grown to the exponential phase and lysed with NP40 buffer (0.2% NP40, 200 mM NaCl, 50 mM Tris pH 7.5, 1 mM PMSF, and protease inhibitors) and glass beads by vigorous shaking for 1 h at 4°C. An 80-μg amount of protein extract was separated by a 7% SDS-polyacrylamide gel. The membranes were incubated overnight at 4°C with rabbit-derived anti-Sir2 antibody (Santa Cruz Biotechnology) or rat-derived anti--α tubulin antibody (Santa Cruz Biotechnology). Secondary antibodies were anti--rabbit immunoglobulin G (IgG)--horseradish peroxidase (HRP; Jackson ImmunoResearch, West Grove, PA) or anti--rat IgG-HRP (Santa Cruz Biotechnology). Detection was performed using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Waltham, MA).
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